Literature DB >> 18092231

Roles of transforming growth factor-alpha in mammary development and disease.

Brian W Booth1, Gilbert H Smith.   

Abstract

Transforming growth factor-alpha (TGFalpha) is a member of the epidermal growth factor (EGF) family. Expression of TGFalpha is highly regulated in response to exogenous cellular signals including cytokines and other growth factors. The growth factor has been found to be indispensable for proper development of many tissues and organs. TGFalpha has also been implicated in numerous disease states including forms of breast cancer. This minireview summarizes the basic biology of TGFalpha and its actions during normal and pathogenic development of the mammary epithelium.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18092231     DOI： 10.1080/08977190701750698

Source DB:  PubMed          Journal:  Growth Factors        ISSN： 0897-7194            Impact factor:   2.511


  14 in total

Review 1.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 2.  The normal microenvironment directs mammary gland development.

Authors:  Erin J McCave; Cheryl A P Cass; Karen J L Burg; Brian W Booth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-08       Impact factor: 2.673

Review 3.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

Review 4.  From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

Review 5.  Genetically engineered ERα-positive breast cancer mouse models.

Authors:  Sarah A Dabydeen; Priscilla A Furth
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 6.  ErbB/EGF signaling and EMT in mammary development and breast cancer.

Authors:  Katharine M Hardy; Brian W Booth; Mary J C Hendrix; David S Salomon; Luigi Strizzi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-04-06       Impact factor: 2.673

7.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Transforming growth factor-alpha stimulates enterocyte proliferation and accelerates intestinal recovery following methotrexate-induced intestinal mucositis in a rat and a cell culture model.

Authors:  Igor Sukhotnik; Dan Shteinberg; Shani Ben Lulu; Yulia Bashenko; Jorge G Mogilner; Benno M Ure; Ron Shaoul; Benhoor Shamian; Arnold G Coran
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

9.  Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases.

Authors:  Zhuangwei Lv; Min Liu; Jinghui Shen; Dong Xiang; Yunfeng Ma; Yanhong Ji
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

Review 10.  Functional selectivity of EGF family peptide growth factors: implications for cancer.

Authors:  Kristy J Wilson; Jennifer L Gilmore; John Foley; Mark A Lemmon; David J Riese
Journal:  Pharmacol Ther       Date:  2008-12-16       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.